| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5841739 | Life Sciences | 2015 | 8 Pages |
Abstract
These results suggest that CDS therapy can play a neuroprotective role in an MPTP mouse model. Neuroprotective disease-modifying therapy may have the potential benefits of early treatment by normalizing compensatory mechanisms and may also help to delay dyskinesia in the later stages of PD.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Xin Yu, Jun-Yi Yao, Jie He, Jing-Wei Tian,